戻る Agenda
Session 1: FDA AdPromo Regulatory Updates from CDER, CBER, and CDRH
Session Chair(s)
Catherine Gray, PHARMD
Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
This session will feature senior representatives from CDER, CBER, CDRH and CVM. The group will provide updates on recent FDA advertising and promotion activities, including compliance actions, process modifications, program areas and goals for 2023.
Learning Objective : At the conclusion of this session, participants should be able to:
- Apply lessons from recent compliance actions to current advertising and promotion review work
- Identify trends in compliance activities over the last year
- Recognize significant advertising and labeling concerns that each FDA medical product Center addresses
Speaker(s)
Speaker
Lisa Stockbridge, PHD
FDA, United States
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
Speaker
Deborah Wolf, JD
FDA, United States
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH